The major focus of the Cancer Cell Networks Program is to promote invesfigafion that will contribute to the generafion of a mechanisfic understanding of aberrant cell regulatory networks supporting tumorigenesis. Our faculty approach this problem from multiple levels of mechanistic resolution, spanning atomic structure through animal models. To promote cancer relevance and synergy across Cancer Center efforts our scientific goals are to: (1) Define the mechanisms and pathways that integrate external and internal regulatory cues at the cell autonomous level: This is a traditional strength at UT Southwestern that is leveraged in the Cancer Cell Networks program to define the basal regulatory states that generate and maintain appropriate restraints on cell growth, proliferation and survival. This goal is integrated with the Molecular Therapeutics and Development and Cancer programs in order to capitalize on the leading-edge human cell model systems and vertebrate genetics being developed in those programs. (2) Establish how aberrant cell regulatory behavior contributes to cell transformation and tumorigenesis: Novel experimental strategies and emerging technology platforms are being employed to isolate the condifional molecular dependencies in tumorigenic regulatory environments that represent authenfic diagnostic or therapeutic targets. This goal is heavily integrated with the Molecular Therapeufics of Cancer Scientific Program to promote study designs that maintain translational relevance through incorporafion of appropriate pafient samples and disease data. Importanfiy, integrafion of this goal with the Chemistry and Cancer program is facilitafing the generation of small molecule leads for in vitro and in vivo target validation and development. (3) Facilitate interactions with translational and clinical scientists to develop strategies to test the therapeutic benefit of modulating cell regulatory components: The Cancer Center leadership has fostered an atmosphere of communication and collaboration between basic science investigators, with expertise in mechanisfic relafionships governing cell behavior, and clinical researchers with acute knowledge and appreciation of the human disease. This both elevates the ability of basic scienfists to develop experimental strategies with greater cancer relevance, and empowers clinicians to move beyond cataloging of cancerassociated phenomena toward defining mechanisfic properties at molecular resolufion.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
United States
Zip Code
Wong, Mandy S; Wright, Woodring E; Shay, Jerry W (2014) Alternative splicing regulation of telomerase: a new paradigm? Trends Genet 30:430-8
Chau, Vincent; Lim, S Kyun; Mo, Wei et al. (2014) Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors. Cancer Res 74:586-97
Iscla, Irene; Wray, Robin; Wei, Shuguang et al. (2014) Streptomycin potency is dependent on MscL channel expression. Nat Commun 5:4891
Fu, Peng; Johnson, Melissa; Chen, Hong et al. (2014) Carpatamides A-C, cytotoxic arylamine derivatives from a marine-derived Streptomyces sp. J Nat Prod 77:1245-8
Park, Jason Y; Gunpat, Joshua; Liu, Li et al. (2014) Red-shifted emission from 1,2-dioxetane-based chemiluminescent reactions. Luminescence 29:553-8
Gerber, David E; Laccetti, Andrew L; Xuan, Lei et al. (2014) Impact of prior cancer on eligibility for lung cancer clinical trials. J Natl Cancer Inst 106:
Yang, Liu; Kwon, Junghee; Popov, Yury et al. (2014) Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology 146:1339-50.e1
Li, Biaoru; Ding, Lianghao; Yang, Chinrang et al. (2014) Characterization of transcription factor networks involved in umbilical cord blood CD34+ stem cells-derived erythropoiesis. PLoS One 9:e107133
Ludlow, Andrew T; Robin, Jerome D; Sayed, Mohammed et al. (2014) Quantitative telomerase enzyme activity determination using droplet digital PCR with single cell resolution. Nucleic Acids Res 42:e104
King, Kelly A; Gordon-Salant, Sandra; Pawlowski, Karen S et al. (2014) Hearing loss is an early consequence of Npc1 gene deletion in the mouse model of Niemann-Pick disease, type C. J Assoc Res Otolaryngol 15:529-41

Showing the most recent 10 out of 83 publications